Price target
8,247.190.000.00%
The 7 analysts offering 1 year price forecasts for TEVA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 12 analysts giving stock ratings to TEVA in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TEVA EPS for the last quarter is 2.23 ILA despite the estimation of 2.09 ILA. In the next quarter EPS is expected to reach 2.28 ILA. Track more of Teva Pharmaceutical Industries Limited financials and stay on top of what is up with the company.
In the next quarter Teva Pharmaceutical Industries Limited revenue is expected to reach 14.77 B ILA. Check out Teva Pharmaceutical Industries Limited revenue and earnings and make informed decisions.
According to analysts, TEVA price target is 8,247.19 ILA with a max estimate of 9,798.52 ILA and a min estimate of 7,427.97 ILA. Check if this forecast comes true in a year, meanwhile watch Teva Pharmaceutical Industries Limited stock price chart and keep track of the current situation with TEVA news and stock market news.
We've gathered opinions of 12 analysts rating TEVA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.